Michael Scolaro

Michael Scolaro

Sep 01, 2017

Group 6 Copy 123
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Antibiotics and Affect: Avenues for Addiction Management

    Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several decades...

    Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

    The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals. A...

    Impact of Soylent Consumption on Human Microbiome Composition

    As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based meal...

    Backer Badge Funded